ReviewPharmaceutics2026

Recent Advances in Nanoparticle-Based Drug Delivery Strategies to Cross the Blood-Brain Barrier in Targeted Treatment of Alzheimer's Disease.

Hoa Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.